Closed
SectorHealthcare
31.29 0.45
24h
Min
30.83
Max
31.35
Income | 441M 334M |
---|---|
Sales | 29M 594M |
P/E Sector Avg | 16.298 63.778 |
EPS | 1.151 |
Dividend yield | 2.83 |
Profit margin | 56.288 |
EBITDA | -511M 362M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +22.97% upside |
Dividend yield Sector Avg | 2.83% 2.39% |
---|---|
Next Earnings | 8 maj 2025 |
Next Dividend date | 13 cze 2025 |
Next Ex Dividend date | 15 maj 2025 |
Market Cap | 18B |
---|---|
Previous open | 30.84 |
Previous close | 31.29 |
By Acuity
50%
50%
180 / 386 Ranking in Healthcare
By Trading Central
Confidence
Strong Bearish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 38.33 USD 22.97%
High 42 USD
Low 33 USD
Based on 4 Wall Street analysts offering 12 month price targets forRoyalty Pharma PLC (Class A) - Dist in the last 3 months.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$